Publikationen

Dr. Tamara Arnoldner - Übersicht über Publikationen

  • Quint T, Wöhrl S, Kinaciyan T. Fixed drug eruption caused by fluconazole-An underdiagnosed but recurrent problem. Contact Dermatitis. 2019 Mar;80(3):172-173. doi: 10.1111/cod.13149. Epub 2018 Nov 12. PMID: 30417394; PMCID: PMC6587866.

  • Quint T, Brunner PM, Sinz C, Steiner I, Ristl R, Vigl K, Kimeswenger S, Neubauer K, Pirkhammer D, Zikeli M, Hoetzenecker W, Reider N, Bangert C. Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis. J Clin Med. 2020 Apr 24;9(4):1241. doi: 10.3390/jcm9041241. PMID: 32344789; PMCID: PMC7230957.

  • Quint T, Jantschitsch C, Maier H. Abducens palsy associated with herpes zoster opthalmicus. Global Journal of Dermatology and Venerology. 2021, 9, 9-11.

  • Quint T, Valerie Dahm, Dariga Ramazanova, Michael A. Arnoldner, Harald Kurz, Stefan Janik, Patrick M. Brunner, Birgit Knerer-Schally, Wolfgang Weninger, Johannes Griss, Robin Ristl, Sven Schneider, Christine Bangert. Omalizumab-induced aspirin tolerance in N-ERD patients is independent of allergic sensitization. JACI in practice 05/21.

  • Zuberbier T, Quint T et al. A concept for integrated care pathways for atopic dermatitis-A GA2 LEN ADCARE initiative. Clin Transl Allergy. 2023 Sep;13(9):e12299. doi: 10.1002/clt2.12299. PMID: 37746794; PMCID: PMC10500634.

  • Bartosik T, Pjevac P, Séneca J, Morgenstern C, Arnoldner T, Gangl K, Sinz C, Campion NJ, Tu A, Stanek V, Bangert C, Schneider S, Eckl-Dorna J. Dupilumab treatment has no effect on the nasal microbiome in patients with NSAID-exacerbated respiratory disease: a longitudinal pilot study. Front Immunol. 2025;16:1234567. PMID: 40503236.

  • Marquart E, Weiss D, Batinic K, Wiesner T, Rohrbeck J, Arnoldner T, Weninger W, Kinaciyan T. Completely ulcerated infantile hemangioma: a diagnostic challenge. Wien Klin Wochenschr. 2025 May 22. doi: 10.1007/s00508-025-02543-5. Online ahead of print. PMID: 40402213.

  • Bangert C, Alkon N, Chennareddy S, Arnoldner T, Levine JP, Pilz M, Medjimorec MA, Ruggiero J, Cohenour ER, Jonak C, Damsky W, Griss J, Brunner PM. Dupilumab-associated head and neck dermatitis shows a pronounced type 22 immune signature mediated by oligoclonally expanded T cells. Nat Commun. 2024 Apr 2;15(1):2839 PMID: 38565563.

  • Brkic FF, Liu DT, Klimbacher R, Campion NJ, Bartosik TJ, Vyskocil E, Stanek V, Tu A, Arnoldner T, Bangert C, Gangl K, Eckl-Dorna J, Schneider S. Efficacy and safety of switching between biologics in chronic rhinosinusitis with nasal polyps or N-ERD. Rhinology. 2023 Aug 1;61(4):320-327. PMID: 37515811.

  • Alkon N, Assen FP, Arnoldner T, Bauer WM, Medjimorec MA, Shaw LE, Rindler K, Holzer G, Weber P, Weninger W, Freystätter C, Chennareddy S, Kinaciyan T, Farlik M, Jonak C, Griss J, Bangert C, Brunner PM. Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis. J Allergy Clin Immunol. 2023 Aug;152(2):420-435. doi: 10.1016/j.jaci.2023.04.019. Epub 2023 May 18. PMID: 37210042.

  • Campion NJ, Doralt A, Lupinek C, Berger M, Poglitsch K, Brugger J, Quint T, Gangl K, Sinz C, Bartosik T, Liu DT, Landegger LD, Tu A, Stanek V, Berger U, Bangert C, Schneider S, Eckl-Dorna J. Dupilumab reduces symptom burden in allergic rhinitis and suppresses allergen-specific IgE production. Allergy 2023. PMID: 36691369

  • Schneider S, Poglitsch K, Morgenstern C, Quint T., Gangl K, Sinz C, Bartosik T, Campion NJ, Liu DT, Landegger LD, Tu A, Stanek V, Rocha-Hasler M, Bangert C, Eckl-Dorna J. Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease (N-ERD). European Respir Journal 2022 Dec. ****PMID: 36549708

  • Dupilumab-induced skin-associated side effects in an Austrian cohort of patients with chronic rhinosinusitis with nasal polyposis. J Dermatology. 2022 Sep 30. doi: 10.1111/1346-8138.16595.

  • Weiss A, Delavenne E, Matias C, Lagler H, Simon D, Li P, Hansen JU, Dos Santos TP, Jana B, Priemel P, Bangert C, Bauer M, Eberl S, Nussbaumer-Pröll A, Anne Österreicher Z, Matzneller P, Quint T, Weber M, Nielsen HM, Rades T, Johansen HK, Westh H, Kim W, Mylonakis E, Friis C, Guardabassi L, Pace J, Lundberg CV, M'Zali F, Butty P, Sørensen N, Nielsen HB, Toft-Kehler R, Guttman-Yassky E, Stingl G, Zeitlinger M, Sommer M. Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trial. Clin Transl. May 2022. PMID: 35522900

  • Bangert C, Villazala-Merino S, Fahrenberger M, Krausgruber T, Bauer WM, Stanek V, Campion NJ, Bartosik T, Quint T, Regelsberger G, Niederberger-Leppin V, Bock C, Schneider S, Eckl-Dorna J. Comprehensive Analysis of Nasal Polyps Reveals a More Pronounced Type 2 Transcriptomic Profile of Epithelial Cells and Mast Cells in Aspirin-Exacerbated Respiratory Disease. Front Immunology. March 2022. PMID: 35418991

  • Lagler H, Bangert C, Quint T, Österreicher Z, Nussbaumer-Pröll A, Eberl S, Weber M, Karer M, Sommer MOA, Zeitlinger M. Comparison of non-invasive Staphylococcus aureus sampling methods on lesional skin in patients with atopic dermatitis. Eur J Clin Microbiol Infect Dis. Feb 22. PMID: 34734346

  • Bangert C, Rindler K, Krausgruber T, Alkon N, Thaler FM, Kurz H, Ayub T, Demirtas D, Fortelny N, Vorstandlechner V, Bauer WM, Quint T, Mildner M, Jonak C, Elbe-Bürger A, Griss J, Bock C, Brunner PM. Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade. Sci Immunol. 2021 Jan 22;6(55):eabe2749. doi: 10.1126/sciimmunol.abe2749. PMID: 33483337

  • Bartosik TJ, Liu DT, Campion NJ, Villazala-Merino S, Janik S, Dahm V, Mueller CA, Vyskocil E, Stanek V, Quint T, Bangert C, Eckl-Dorna J, Schneider S. Differences in men and women suffering from CRSwNP and AERD in quality of life. Eur Arch Otorhinolaryngol. 2021 May;278(5):1419-1427. doi: 10.1007/s00405-020-06418-5. Epub 2020 Oct 15. PMID: 33063145.

  • Schneider S, Campion NJ, Villazala-Merino S, Liu DT, Bartosik T, Landegger LD, Ahmadi N, Mueller CA, Vyskocil E, Stanek V, Quint T, Bangert C, Eckl-Dorna J. Associations between the Quality of Life and Nasal Polyp Size in Patients Suffering from Chronic Rhinosinusitis without Nasal Polyps, with Nasal Polyps or Aspirin-Exacerbated Respiratory Disease. J Clin Med. 2020 Mar 28;9(4):925. doi: 10.3390/jcm9040925. PMID: 32231056; PMCID: PMC7230739.

  • Borik L, Petzelbauer P, Quint T, Wöhrl S, Kinaciyan T, Heil PM. Type IV allergy to antimalarials can mimic cutaneous manifestations of lupus erythematosus. J Eur Acad Dermatol Venereol. 2019 Mar;33(3):e94-e96. doi: 10.1111/jdv.15249. Epub 2018 Oct 8. PMID: 30223310.

  • Posch C, Monshi B, Quint T, Vujic I, Lilgenau N, Rappersberger K. The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): Retrospective analysis of 74 patients. J Am Acad Dermatol. 2017 Jul;77(1):123-129.e5. doi: 10.1016/j.jaad.2017.01.055. Epub 2017 Apr 1. PMID: 28377030.

  • Quint T, Bangert C. Biologika-Therapie der atopischen Dermatitis. Hautnah. 2021, 20(1):37-44.

  • Quint T, Bangert C. Neue Therapiemöglichkeiten der atopischen Dermatitis. JATROS. 2/2021.